Comparing Reduced Intensity Allo HCT to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
National Marrow Donor Program
Start Date
April 29, 2014
End Date
June 30, 2020
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
National Marrow Donor Program
Start Date
April 29, 2014
End Date
June 30, 2020